Understanding Freestanding ER Revenue Models
For investors, healthcare operators, and capital partners evaluating freestanding emergency room (FSER) opportunities, understanding the revenue model is foundational. FSER economics differ meaningfully from traditional healthcare businesses — there are no elective procedures to be scheduled, no subscription-based primary care relationships, and no long-term inpatient stays. Revenue is generated visit by visit, driven by patient volume, acuity mix, and payer composition. This article provides a comprehensive breakdown of how freestanding ERs generate revenue, where the economic levers are, and what separates high-performing revenue operations from underperforming ones.
The Three Revenue Pillars
Freestanding ER revenue is built on three distinct pillars, each with its own billing mechanisms, reimbursement dynamics, and optimisation strategies.
1. Facility Fees
The facility fee is the primary revenue component for most FSERs, typically representing 55–65 per cent of total revenue. This charge covers the cost of providing the emergency care environment — the physical facility, nursing staff, equipment, supplies, and operational overhead required to deliver emergency services.
Facility fees are billed using Current Procedural Terminology (CPT) codes that correspond to the level of emergency department evaluation and management services provided. The Emergency Department Evaluation and Management (E/M) codes — 99281 through 99285 — represent ascending levels of complexity:
- 99281 (Level 1): Self-limited or minor problems requiring minimal decision-making. Lowest reimbursement tier.
- 99282 (Level 2): Low-to-moderate severity problems. Straightforward medical decision-making.
- 99283 (Level 3): Moderate severity. Requires moderate-complexity decision-making. This is the most common billing level at many FSERs.
- 99284 (Level 4): High severity with urgent evaluation required. Significant diagnostic workup and treatment.
- 99285 (Level 5): Highest severity. Immediate, significant threat to life or physiological function. Most complex decision-making, often involving multiple diagnostic studies and interventions.
The distribution of E/M levels — the facility's acuity mix — is one of the most significant drivers of per-visit revenue. A facility that sees a higher proportion of Level 4 and Level 5 patients will generate meaningfully more revenue per visit than one that primarily treats Level 2 and Level 3 cases. However, acuity mix is largely determined by market characteristics and clinical capability — it is not something that can be artificially inflated without compliance risk.
In addition to E/M facility fees, FSERs bill separately for diagnostic procedures performed during the visit — CT scans, X-rays, ultrasounds, laboratory tests, and EKGs. These ancillary charges are billed under their own CPT codes and represent an important supplementary revenue stream.
2. Professional Fees
Professional fees represent the charges for physician services — the clinical evaluation, medical decision-making, and treatment provided by the emergency physician. Professional fees typically account for 20–30 per cent of total FSER revenue.
Professional fees are billed using the same E/M code levels (99281–99285) but under the physician's National Provider Identifier (NPI) rather than the facility's. The physician's documentation must support the coded level of service. Reimbursement rates for professional fees vary by payer and are generally lower on a per-code basis than facility fees, but they are a critical component of the overall revenue equation.
The professional billing model at an FSER can take several forms:
- Employed-physician model: The FSER employs physicians directly and bills professional fees under the facility's tax identification number. This model maximises revenue integration and simplifies payer contracting.
- Independent-contractor model: Physicians contract with the FSER as independent contractors and may bill professional fees independently or through a separate physician group. Revenue split arrangements vary.
- Third-party staffing model: An emergency medicine staffing company provides physicians and handles professional billing. This model simplifies physician recruitment but typically results in lower net professional fee revenue to the facility operator.
The choice of professional billing model has significant implications for total revenue capture, payer-contract negotiation leverage, and operational control. Investors should understand which model the target FSER uses and how it affects the financial model. Learn more about how Focus Health structures its operational models to optimise revenue capture.
3. Ancillary Services Revenue
Ancillary services — diagnostic imaging, laboratory testing, and procedural interventions — generate the remaining 15–25 per cent of FSER revenue. This category includes:
- CT scans: One of the highest-reimbursement ancillary services. CT scans of the head, abdomen, and chest are among the most frequently ordered studies in emergency medicine and generate significant per-unit revenue.
- X-rays: Lower per-unit reimbursement than CT but high volume. Extremity X-rays, chest X-rays, and abdominal films are frequently ordered across all acuity levels.
- Ultrasound: Point-of-care ultrasound is increasingly used for abdominal, pelvic, and vascular assessments. Reimbursement varies by study type and payer.
- Laboratory testing: CBC, BMP, troponin, urinalysis, rapid strep, influenza/COVID testing, and drug screens represent the core lab menu. Laboratory revenue is moderate on a per-test basis but adds up significantly across volume.
- EKG: Standard diagnostic for chest pain, palpitations, and other cardiac presentations. Modest reimbursement but high utilisation frequency.
- Procedural services: Laceration repair, fracture splinting, abscess drainage, and IV-fluid administration generate procedure-specific codes that supplement E/M revenue.
Facilities with on-site CT scanners, in-house laboratories, and ultrasound capability capture more ancillary revenue per visit than those that must refer patients to external facilities for imaging or lab work. Focus Health's facility design standards ensure that every FSER is equipped with comprehensive diagnostic capability from day one.
Payer-Mix Impact on Revenue
Payer mix — the distribution of patients across commercial insurance, Medicare, Medicaid, and self-pay categories — is the single most impactful variable on per-visit revenue. The same clinical service can generate dramatically different revenue depending on the patient's insurance status.
Commercial Insurance
Commercial payers (BCBS, Aetna, UnitedHealthcare, Cigna, and others) represent the highest reimbursement category for FSERs. Most freestanding ERs operate as out-of-network providers, with reimbursement governed by the No Surprises Act and state balance-billing protections. A Level 4 emergency visit with CT and lab work can generate $1,500–3,000+ in combined facility and professional fees, depending on the qualifying payment amount (QPA) and independent dispute resolution (IDR) outcomes. High commercial insurance penetration in the surrounding trade area is the most important payer-mix characteristic for FSER financial performance.
Self-Pay
Self-pay patients — those without insurance — represent both a revenue challenge and an access imperative. FSERs are required by EMTALA to provide a medical screening examination and stabilising treatment regardless of ability to pay. Self-pay collection rates typically range from 10–30 per cent of billed charges, depending on the facility's pricing policies, payment-plan offerings, and collection practices.
The interplay of these payer categories determines the facility's blended revenue per visit — the single most important metric for FSER financial modelling. A facility in a high-commercial, low-self-pay market may generate $1,200–1,800 in blended revenue per visit, while a facility in a high-self-pay corridor may generate $600–900. This differential has enormous implications for operating margins and investment returns.
Our market evaluation methodology places payer-mix analysis at the centre of site-selection decisions, ensuring that every Focus Health facility is positioned in a corridor with favourable insurance demographics.
Volume-Driven vs Acuity-Driven Models
FSER operators generally pursue one of two strategic orientations — each with distinct implications for revenue, cost structure, and brand positioning.
Volume-Driven Model
Volume-driven FSERs optimise for patient throughput. They typically locate in high-traffic, high-visibility locations and position themselves as convenient alternatives to hospital ERs for a wide range of emergency presentations. Marketing emphasises short wait times, convenient access, and a broad scope of services. Revenue growth is primarily driven by increasing the number of patients seen per day.
Volume-driven facilities tend to have a broader acuity distribution (more Level 2 and Level 3 visits) and a lower average revenue per visit, offset by higher total visit counts. This model requires efficient throughput processes, lean staffing, and disciplined cost management to maintain margins at scale.
Acuity-Driven Model
Acuity-driven FSERs focus on clinical capability and positioning as a true emergency medicine destination. They invest in advanced diagnostics (multi-slice CT, comprehensive lab menus, point-of-care ultrasound), experienced physicians, and clinical protocols that attract higher-acuity patients — the chest pains, strokes, fractures, and paediatric emergencies that generate Level 4 and Level 5 billing. Revenue growth is driven by increasing the average revenue per visit through clinical complexity.
Acuity-driven facilities may see fewer total patients but generate higher per-visit revenue, resulting in comparable or superior total revenue on lower patient volumes. This model requires greater diagnostic-equipment investment and more experienced clinical staffing but can deliver stronger margins with lower throughput pressure.
Most successful FSERs blend elements of both approaches — maintaining efficient throughput for lower-acuity visits while ensuring the clinical capability to manage high-acuity emergencies that drive premium reimbursement.
Revenue Cycle Management: Where Revenue Is Won or Lost
The revenue cycle — the process of capturing, billing, and collecting payment for services rendered — is where theoretical revenue becomes actual cash. Effective revenue-cycle management (RCM) is one of the most significant operational differentiators between high-performing and underperforming FSERs.
Key RCM components include:
- Insurance verification: Confirming coverage and benefits at the time of service. Real-time eligibility checks reduce claim denials and surprise billing situations.
- Clinical documentation: Physician documentation must support the coded level of service. Underdocumentation results in downcoding and lost revenue; overdocumentation creates compliance risk.
- Charge capture: Ensuring that all billable services — E/M, imaging, lab, procedures — are accurately captured and coded. Missed charges are revenue that simply disappears.
- Claim submission: Clean claims submitted promptly result in faster payment. Claim denial rates below 5 per cent are a benchmark for well-managed RCM operations.
- Payment posting and reconciliation: Accurately posting payments, identifying underpayments, and managing contractual adjustments ensures that payer obligations are fully met.
- Denial management: Systematically appealing denied claims and identifying denial patterns allows operators to correct root causes and recover lost revenue.
- Self-pay collections: Implementing transparent pricing, payment plans, and financial-assistance programmes maximises self-pay collections while maintaining community goodwill.
The difference between a top-quartile and bottom-quartile RCM operation at an FSER can represent 15–25 per cent of total revenue — a gap that flows directly to the bottom line. Investors should evaluate RCM capabilities with the same scrutiny they apply to clinical operations and market selection.
Common Misconceptions About FSER Revenue
Several misconceptions persist about freestanding ER revenue models. Investors should be aware of these and evaluate opportunities accordingly.
- "FSERs charge more than hospital ERs." FSER facility fees are often comparable to or lower than hospital emergency department fees for equivalent services. The perception of higher charges is frequently driven by out-of-network billing situations — a dynamic that has been significantly addressed by balance-billing reform and the No Surprises Act.
- "Most FSER patients are low-acuity." While FSERs do see lower-acuity patients, a significant and growing portion of visits involve true emergencies — chest pain, fractures, lacerations requiring repair, paediatric febrile illness, and acute abdominal conditions. Acuity profiles at well-positioned FSERs are often comparable to community hospital emergency departments.
- "Revenue declines after an initial surge." Patient volume at a new FSER typically follows a ramp curve — starting low, building over 6–12 months, and stabilising at a sustainable level. Facilities that launch with strong payer contracts, experienced clinical teams, and community-awareness programmes generally see sustained volume growth post-stabilisation rather than decline.
- "Self-pay patients make FSERs unprofitable." While high self-pay volumes reduce per-visit revenue, commercially insured patients cross-subsidise self-pay care effectively when the overall payer mix is favourable. The key is trade-area selection — choosing locations where commercial insurance penetration is high enough to maintain strong blended revenue.
A thorough understanding of these dynamics — supported by the analysis in our investor checklist for healthcare operators — is essential for making informed investment decisions in the FSER sector.
Optimising FSER Revenue: Operational Levers
Operators have several levers available to optimise FSER revenue performance:
- Out-of-network billing optimisation: As an out-of-network provider, maximising reimbursement requires expertise in No Surprises Act compliance, qualifying payment amount (QPA) analysis, and independent dispute resolution (IDR) processes. Building efficient out-of-network claims workflows and appeals processes is the highest-impact revenue lever for FSER operators.
- Clinical capability investment: On-site CT, comprehensive lab menus, and point-of-care ultrasound increase diagnostic intensity per visit, driving ancillary revenue and supporting higher-level E/M coding where clinically appropriate.
- Documentation and coding excellence: Investing in physician documentation training and coding-quality audits ensures that clinical complexity is accurately captured and billed, preventing revenue leakage from undercoding.
- Throughput optimisation: Reducing door-to-discharge times allows facilities to see more patients per day without adding staffing. Process improvements in triage, diagnostics, and discharge workflows drive volume-based revenue growth.
- Community awareness: Local marketing, employer outreach, and digital presence ensure that the surrounding community knows the FSER exists and views it as a trusted alternative to hospital ERs.
Conclusion
Freestanding ER revenue models are multifaceted, combining facility fees, professional charges, and ancillary services into a per-visit economic engine that is fundamentally driven by payer mix, volume, and acuity. Investors who understand these dynamics — and who partner with operators capable of optimising each revenue lever — are well positioned to capture the attractive returns that FSER investments offer.
The revenue model rewards operators who combine clinical excellence with financial discipline: strong payer contracting, accurate documentation, efficient throughput, and effective revenue-cycle management. At Focus Health, these operational priorities are embedded in every facility we develop and manage.
Learn More About FSER Investment Economics
Explore Focus Health’s investor resources or review our market evaluation approach to understand how we identify and develop high-performing FSER opportunities.



